Mary‐Ann Lane

715 total citations
17 papers, 551 citations indexed

About

Mary‐Ann Lane is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mary‐Ann Lane has authored 17 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Mary‐Ann Lane's work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and T-cell and Retrovirus Studies (2 papers). Mary‐Ann Lane is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and T-cell and Retrovirus Studies (2 papers). Mary‐Ann Lane collaborates with scholars based in United States. Mary‐Ann Lane's co-authors include Geoffrey M. Cooper, Jerome Ritz, Phyllis B. Blair, Alan M. Diamond, Isaac J. Powell, Jill A. Macoska, Wael Sakr, Antonio Sastre, Jirayr R. Roubinian and Aishwariya Sharma and has published in prestigious journals such as Nature, Cell and The Journal of Immunology.

In The Last Decade

Mary‐Ann Lane

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary‐Ann Lane United States 10 286 151 131 129 67 17 551
J. Watson United Kingdom 12 302 1.1× 119 0.8× 80 0.6× 72 0.6× 29 0.4× 20 567
De-Hui Ku United States 12 510 1.8× 159 1.1× 87 0.7× 98 0.8× 121 1.8× 12 689
Judith A. Kantor United States 14 322 1.1× 280 1.9× 414 3.2× 132 1.0× 27 0.4× 18 695
M T Maunoury France 15 152 0.5× 306 2.0× 505 3.9× 88 0.7× 45 0.7× 18 762
Christophe Ronsin France 12 472 1.7× 154 1.0× 317 2.4× 54 0.4× 26 0.4× 13 925
Melissa S. DeRycke United States 10 163 0.6× 79 0.5× 129 1.0× 74 0.6× 85 1.3× 14 439
U Bregula Sweden 7 219 0.8× 102 0.7× 49 0.4× 76 0.6× 42 0.6× 14 365
Michiyo Hatanaka Japan 16 273 1.0× 39 0.3× 231 1.8× 102 0.8× 117 1.7× 33 670
Michael Nawrath Switzerland 15 291 1.0× 125 0.8× 199 1.5× 85 0.7× 33 0.5× 23 544
Ph. Hageman Netherlands 7 385 1.3× 183 1.2× 196 1.5× 64 0.5× 10 0.1× 10 636

Countries citing papers authored by Mary‐Ann Lane

Since Specialization
Citations

This map shows the geographic impact of Mary‐Ann Lane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Ann Lane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Ann Lane more than expected).

Fields of papers citing papers by Mary‐Ann Lane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary‐Ann Lane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Ann Lane. The network helps show where Mary‐Ann Lane may publish in the future.

Co-authorship network of co-authors of Mary‐Ann Lane

This figure shows the co-authorship network connecting the top 25 collaborators of Mary‐Ann Lane. A scholar is included among the top collaborators of Mary‐Ann Lane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary‐Ann Lane. Mary‐Ann Lane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sharma, Aishwariya & Mary‐Ann Lane. (2019). Tumor Lysis Syndrome from Autolysis in Prostate Cancer. A6546–A6546. 1 indexed citations
2.
Macoska, Jill A., Isaac J. Powell, Wael Sakr, & Mary‐Ann Lane. (1992). Loss of the 17p Chromosomal Region in a Metastatic Carcinoma of the Prostate. The Journal of Urology. 147(4). 1142–1146. 37 indexed citations
3.
Becker, Dorothea, Mary‐Ann Lane, & Geoffrey M. Cooper. (1984). Transformation of NIH 3T3 Cells by DNA of the MCF-7 Human Mammary Carcinoma Cell Line Induces Expression of an Endogenous Murine Leukemia Provirus. Molecular and Cellular Biology. 4(11). 2247–2252. 1 indexed citations
4.
Cooper, Geoffrey M. & Mary‐Ann Lane. (1984). Cellular transforming genes and oncogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 738(1-2). 9–20. 80 indexed citations
5.
Diamond, Alan M., Geoffrey M. Cooper, Jerome Ritz, & Mary‐Ann Lane. (1983). Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas. Nature. 305(5930). 112–116. 144 indexed citations
6.
Lane, Mary‐Ann, et al.. (1982). Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms. Cell. 28(4). 873–880. 144 indexed citations
7.
Lane, Mary‐Ann, et al.. (1982). Activation of a cellular transforming gene in tumours induced by Abelson murine leukaemia virus. Nature. 300(5893). 659–661. 28 indexed citations
8.
Blair, Phyllis B. & Mary‐Ann Lane. (1980). Age‐ and tumor‐correlated changes in functional antibody responses to MTV in neonatally infected mice. International Journal of Cancer. 25(2). 273–279. 1 indexed citations
9.
Blair, Phyllis B. & Mary‐Ann Lane. (1978). Early detection of tumor‐specific antibodies to mammary carcinoma. International Journal of Cancer. 21(4). 476–481. 2 indexed citations
10.
Lane, Mary‐Ann. (1978). Muscarinic Cholinergic Activation of Mouse Spleen Cells Cytotoxic to Tumor Cells In Vitro<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 61(3). 923–6. 8 indexed citations
11.
Sastre, Antonio, et al.. (1977). Muscarinic cholinergic binding sites in the developing avian heart. Developmental Biology. 55(1). 201–205. 18 indexed citations
12.
Blair, Phyllis B. & Mary‐Ann Lane. (1977). Effect of Immune Manipulation on Natural Immune Responses to Murine Mammary Tumor Antigens2. JNCI Journal of the National Cancer Institute. 59(1). 251–257. 7 indexed citations
13.
Roubinian, Jirayr R., et al.. (1976). Stimulation of Immune Mechanisms against Mammary Tumors by Incomplete T Cell Depletion,2. The Journal of Immunology. 117(5_Part_2). 1767–1773. 9 indexed citations
14.
Lane, Mary‐Ann, et al.. (1975). Characterization of Cytotoxic Effector Cells in the Mouse Mammary Tumor System. The Journal of Immunology. 114(1_Part_1). 24–29. 15 indexed citations
15.
Blair, Phyllis B. & Mary‐Ann Lane. (1975). Non-T Cell Killing of Mammary Tumor Cells by Spleen Cells: Secretion of Antibody and Recruitment of Cells. The Journal of Immunology. 115(1). 184–189. 21 indexed citations
16.
Blair, Phyllis B., et al.. (1975). Blocking of Spleen Cell Activity against Target Mammary Tumor Cells by Viral Antigens. The Journal of Immunology. 115(1). 190–194. 15 indexed citations
17.
Blair, Phyllis B. & Mary‐Ann Lane. (1974). Immunologic Evidence for Horizontal Transmission of MTV. The Journal of Immunology. 113(5). 1446–1449. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026